2022 annual financial data
AgomAb Therapeutics 2022 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -22,634,000 EUR and net income was -8,142,000 EUR.
Operating cash flow was Not available.
Get free AgomAb Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 EUR
- Operating income
- -22,634,000 EUR
- Net income
- -8,142,000 EUR
- Operating cash flow
- Not available